Search This Blog

Monday, September 1, 2025

Omar’s net worth skyrockets to as much as $30M, months after denying millionaire status

 Rep. Ilhan Omar (D-Minn.) reported a net worth of up to $30 million in her latest financial disclosure – a document filed just months after the congresswoman dismissed claims she was a millionaire as “ridiculous” and “categorically false.” 

The disclosure, filed in May, shows the far-left “Squad” lawmaker and her husbandTim Mynett, experienced a roughly 3,500% increase in net worth last year, compared to 2023

Rep. Ilhan Omar speaking at a news conference.
The surge in wealth detailed in Omar’s disclosure is the result of an explosion in the value of assets held by her husband’s venture capital firm and winery.AP

The surge in the couple’s wealth was first reported by the Washington Free Beacon on Monday. 

The financial gains came from Mynett’s two businesses, a Santa Rosa, Calif.-based winery and venture capital firm headquartered in Washington, DC. 

Omar valued the winery’s assets at between $1,000,000 and $5,000,000 in her latest disclosure. By comparison, the winery, eStCru LLC, was only worth between $15,000 and $50,000 in Omar’s previous financial disclosure. 

More dramatic was the explosion in growth experienced by Mynett’s venture capital firm, Rose Lake Capital LLC. 

Rose Lake Capital’s assets were valued at between $5,000,000 to $25,000,000 by the end of 2024. The company had less than $1,000 in assets the previous year. 

Notably, income from the venture capital firm is listed as “none” in 2024 but between $15,000 and $50,000 the previous year. 

Rose Lake Capital claims to have $60 billion in assets under management, according to the company’s website. 

The company touts its “deep global networks built from on-the-ground work in more than 80 countries working across business, politics, banking and diplomacy.” 

It offers clients “expertise” in several facets of business, including structuring “legislation.” 

Ilhan Omar campaigning, waving to supporters.
Ilhan Omar denied she was a millionaire earlier this year.AP

The congresswoman cried “disinformation” in February, when asked about online speculation that she was a secret millionaire. 

“Since getting elected, there has been a coordinated right-wing disinformation campaign claiming all sorts of wild things, including the ridiculous claim I am worth millions of dollars which is categorically false,” Omar told Business Insider

“I am a working mom with student loan debt. Unlike some of my colleagues — and similar to most Americans — I am not a millionaire and am raising a family while maintaining a residence in both Minneapolis and DC, which are among the most expensive housing markets in the country,” she added.

The disclosure does list as much as $100,000 in credit card and student loan debt owed by Omar.

She also has between $1,000 and $15,000 in her congressional credit union savings account and another $15,000 to $50,000 in a retirement fund from her time in the Minnesota state legislature.

Omar’s office did not immediately respond to The Post’s request for comment. 

https://nypost.com/2025/09/01/us-news/rep-ilhan-omars-net-worth-skyrockets-to-as-much-as-30-million-months-after-denying-she-was-a-millionaire/

Noem accuses CBS of ‘shamefully’ editing interview on Abrego Garcia to ‘whitewash’ MS-13 tie

 Homeland Security Secretary Kristi Noem went on a tirade against CBS News on Sunday over allegations the network edited her interview about alleged MS-13 gang member Kilmar Abrego Garcia, an illegal migrant that theTrump administration deported to El Salvador earlier this year.

Noem was on CBS’ “Face the Nation” discussing Abrego Garcia Sunday morning, she said on X, but noticed by afternoon that the footage had been clipped to remove part of her answer.

“This individual was a known human smuggler, a MS-13 gang member, an individual who was a wife beater, and someone who was so perverted that he solicited nude photos from minors, and even his fellow human traffickers told him to knock it off, he was so sick in what he was doing and how he was treating small children,” the DHS chief said in the full, unaired clip.

Noem claimed a portion of her interview was cut from CBS.AP
Comparison of Kristi Noem’s uncut and CBS-aired interview segments.X/@Sec_Noem

“So he needs to never be in the United States of America and our administration is making sure we’re doing all that we can to bring him to justice,” she added.

“Secretary Noem’s “Face The Nation” interview was edited for time and met all CBS News standards,” a CBS rep told The Post. “The entire interview is publicly available on YouTube, and the full transcript was posted early Sunday morning at CBSNews.com

Noem wrote on X, “This morning, I joined CBS to report the facts about Kilmar Abrego Garcia. Instead, CBS shamefully edited the interview to whitewash the truth about this MS-13 gang member and the threat he poses to American public safety.”

A US federal immigration judge ruled in 2019 that Abrego Garcia couldn’t be deported to El Salvador due to threats from local gangs — but the Trump administration flew him along with hundreds of other alleged gang members out of the country to a megaprison in the Central American nation earlier this year.

Kilmar Abrego Garcia speaks during a rally and prayer vigil for him before he enters a U.S. Immigration and Customs Enforcement (ICE) field office on August 25, 2025 in Baltimore, Maryland.Getty Images

The Trump administration claimed he was a member of the violent MS-13 gang — a US-designated foreign terrorist organization — based on a determination during that 2019 court proceeding.

Abrego Garcia and his defense attorneys have denied the allegation.

Democrats visited with and advocated for Abrego Garcia, saying he was “wrongfully” removed to El Salvador and kept there for weeks first at the notorious prison CECOT and then at a lower-security facility.

The purported Salvadoran gangbanger was eventually brought back to the US in June and charged with human smuggling, but released briefly before that trial only to be apprehended again by ICE on Aug. 25

He now faces the possibility of being deported to Uganda after having declined to plead guilty to the smuggling charges as part of an agreement that would send him to Costa Rica instead.

Abrego Garcia’s lawyers are still working on getting him asylum in the US. His first attempt in 2019 was denied, but if this one is approved, it could put him on a pathway to a green card and American citizenship.

https://nypost.com/2025/09/01/us-news/kristi-noem-accuses-cbs-of-editing-her-interview-on-kilmar-abrego-garcia-to-whitewash-ms-13-gang-affiliation/

Why 'Eating The Rich' Undermines Everyone's Prosperity

 by David Hebert via TheDailyEconomy.org,

recent report from The Heritage Foundation argues that “the wealthy” are not “idle idols” but are instead owners and investors of wealth-creating ventures.

Through their ownership of productive assets, they are the driving force behind overall wealth creation in the country and, in some cases, the world.  The report reveals a crucial truth that is often lost in today’s political rhetoric: the overwhelming majority of American wealth among the most wealthy (88.2 percent) consists of assets linked directly to businesses and economic production. Despite the commonly accepted belief that millionaires hold their money in real estate or “yachts, sports cars, private planes, gold bars, and jewelry,” most of that wealth is investment, not consumption goods.

Building on this important truth, we emphasize two additional insights that may inform our current policy debates, particularly as the Trump administration seeks to expand government ownership stakes in private companies.

First, we must acknowledge that capitalism, for all its flaws in practice, is fundamentally a system that rewards serving others, not exploiting them.

Look at Henry Ford: he benefited tremendously from figuring out how to mass produce cars such that the common man was able to afford a vehicle. But I submit to you that, while he became fabulously wealthy from his innovations, the real winners of this exchange were people like you and me. Everyday Americans received better access to transportation, fundamentally transforming our lives. People like Ford already had access to this then-privilege, so while he may command more wealth as a result of his efforts, the efforts themselves improved our lives much more than his.

The people who create medical treatments and vaccines against disease also often become wealthy. But when people all around the world are freed from contracting diseases, enjoying a fundamentally better and happier life, the wealth gained by their inventors seems small. 

Or think of tech moguls like Bill Gates, Steve Jobs, and Tim Cook. By bringing computing power to the masses, they fundamentally transformed the way we all live our everyday lives.

Consider this ad for computers from 1990:

In today’s dollars, these items would cost $6,590, $2,533, and $5,829, respectively. Also in 1990, the average nominal pay for the whole United States was $23,602, meaning that the average person would have to work 220 hours, 84 hours, and 194 hours respectively, to buy these items. Today, with an average wage of $36.44 ($72,880 annually), the hours worked to afford these items (at their 2025 prices) would be 181, 70, and 160.

But we wouldn’t be buying computer equipment from 1990, anyway. Computer prices have actually fallen dramatically. At the time of this writing, a comparable baseline iMac costs $1,299 (35 hours of work).  The latest LaserJet printer from HP costs $169 (4.6 hours).  IBM sold its computer hardware division to Lenovo in 2005, and a Lenovo desktop computer now costs $859 (23.5 hours). Even if we ignore the massive improvements in quality and the explosion of computing power contained in those devices, computing power has never been more affordable. Millions of careers were transformed by the efforts of Bill Gates, Steve Jobs, Tim Cook, and everyone else from engineer to assembly line at Microsoft and Apple. And while the CEOs and employees of these companies have surely become wealthier, the real winners of the innovations are everyday people like you and me.

In a free society characterized by capitalism, wealth is generated by serving others.

Those who can best serve others — and consume less than they generate — find themselves amassing what we define as “wealth.”

The second lesson we can glean from the Heritage study is what the ultra-wealthy actually do with the wealth they amass. Nearly 90 percent of their fortunes are tied up in productive economic activity, not luxury consumption. Only three percent of the top one percent’s wealth is in consumer durables — things like cars, furniture, and jewelry. For the bottom quintile, that ratio is likely to be 15-20 percent.  

Far from being “idle rich,” the wealthy invest their fortunes, providing the capital necessary to fund increased economic activity. For the rest of us, that means more jobs, more production, and better access to the goods and services that enable us to live healthily and wealthily, however we choose to define these terms.

That investment cycle also helps explain why “eating the rich” is a recipe for disaster. Sticking the rich with exorbitant federal taxes can only mean that wealth is removed from productive economic uses to pay for public sector malfeasance. Policymakers are not taking gold coins out of a swimming pool à la Scrooge McDuck, they’re taking investments out of the private sector. The loss of capital impacts not the rich, primarily, but the prosperity that the rest of us have come to enjoy and depend upon.

The reality is that the wealth of the wealthiest people in America largely represents the market’s assessment of their ability to continue serving their customers in the future. As new information comes to light, this assessment can and does change. Tesla, for example, started off white-hot, with stock prices skyrocketing. But lately, after the abysmal launch of the Cybertruck and delays in its production and delivery, combined with some of Musk’s stupendously bad investments, the market has revised its assessment of Tesla downward.  As a result, Musk has lost more than $80 billion in wealth thus far in 2025 alone.

This brings us to a troubling development: President Trump, Congressional Republicans, and members of the so-called New Right have recently floated the idea that we should tax the rich more. Even more alarmingly, these same people hold that the federal government should take equity stakes in private companies. This is a fundamental departure from the principles that allowed for the creation of the wealth policymakers now wish to strip away, and a complete rejection of lower-tax, small-government Republicanism.

President Trump is “taking a 10 percent stake in Intel,” making the federal government the single largest stakeholder of the company. Earlier this year, the sale of US Steel to Nippon was approved, contingent on the US government receiving a “golden share.” While Trump is in office, this golden share is held by the President (i.e. Donald Trump), and after he leaves office, it will revert to being held by the Treasury and Commerce Departments. Importantly, while he is in office, the President will have veto power over some production and wage decisions. Not wishing to be left behind, the Pentagon is taking a 15 percent stake in MP Materials, a producer of rare-earth magnets, among other things.

All of this shifts the nation away from the capitalism that created an economy (and indeed, society) the likes of which has never been seen in human history and toward the type of capitalism found in, say, China. Trying to “out-China” China is a fool’s errand.
The reality is that economies, societies, and the nation itself are best served when individual people are given the freedom and tools to succeed, not when government bureaucrats pick winners and losers.

In a free-market, capitalist system like the one the US for the most part enjoys, the best way to serve oneself is by serving others.

https://www.zerohedge.com/personal-finance/why-eating-rich-undermines-everyones-prosperity

Low-Dose Oral Anticoagulant Slashes Recurrence After Provoked VTE

 Extended low-dose apixaban (Eliquis) after venous thromboembolism (VTE) provoked by events like trauma or surgery in patients with obesity or other enduring risk factors dramatically reduced recurrences without much risk of major bleeding, the HI-PRO trial showed.

Twice daily 2.5-mg doses of the direct oral anticoagulant (DOAC) for 12 months slashed the rate of symptomatic recurrent VTE over that period by a relative 87%, on par with the effect of extended-duration secondary prevention in unprovoked VTE, reported Gregory Piazza, MD, of Brigham and Women's Hospital in Boston, at the European Society of Cardiologyopens in a new tab or window meeting.

The rate dropped to just 1.3% compared with 10.0% among patients given placebo (P<0.001), according to the findings simultaneously published in the New England Journal of Medicineopens in a new tab or window.

Major bleeding occurred in one patient out of 300 in the apixaban group and none in the placebo group. Clinically relevant nonmajor bleeding rates were 4.8% and 1.7%, respectively (HR 2.68, 95% CI 0.96-7.43, P=0.06).

"The most striking finding of this trial is the unexpectedly high risk of recurrence in the placebo group at 1 year, which more closely resembled findings for unprovoked VTE than for truly provoked events," wrote Neil A. Zakai, MD, of the University of Vermont in Burlington, in an accompanying editorialopens in a new tab or window.

"For decades, the guidance was simple: treat a provoked VTE -- one caused by a transient factor such as surgery, trauma, or immobility -- for 3 to 6 months, stop, and move on. Safer anticoagulants and emerging evidence now challenge this long-held approach," he noted, with experts arguing for distinctions such as major versus minor and transient as compared with persistent.

The new findings "invite us to reconsider whether the 'provoked' label is a license to discontinue anticoagulation or the beginning of a more nuanced conversation with our patients," Zakai wrote.

He pointed out that the findings probably reflected the definition of "provoked," relying on clinician judgment rather than standardized definitions for provoking factors unlike in previous epidemiologic studies. The most common provoking factors for the index VTE were surgery (33.5%), immobility (31.3%), trauma (19.2%), and acute medical illness (18.3%). But minor triggers were not uncommon, such as long-haul travel (16.7%). Only 9.3% of the patients had been hospitalized in the 3 months preceding the index VTE event.

The trial was done at a single-center, with more than half of the patients enrolled by a single clinician. While this raises the possibility of a definition of provoked VTE reflecting local practice patterns, it reflects everyday clinical practice, Zakai wrote.

The researchers agreed that the dichotomy of provoked versus unprovoked is "insufficient to determine the duration of anticoagulation." Enduring risk factors -- obesity for about half of the study population, chronic inflammatory or autoimmune disorder for about half, atherosclerotic cardiovascular disease for about 30%, and chronic lung disease for around 20% -- appeared to select a group that approximated recurrence risk of high-risk patients (>8%), they argued.

Post hoc subgroup analysis found consistent impact on the primary endpoint in patients with both major and minor transient provoking factors.

The 600 adults in the trial had VTE after a transient provoking factor and had at least one enduring risk factor. After completing at least 3 months of anticoagulation, they were randomly assigned to double-blind treatment with oral apixaban (2.5 mg twice daily) or placebo for 12 months. VTE with active cancer was excluded, as was anyone with active or recent bleeding events.

The participants' mean age was 59.5; 57.0% were female; and 19.2% had non-white race.

A secondary composite outcome of cardiovascular death, nonfatal myocardial infarction, stroke or transient ischemic attack, systemic embolism, major adverse limb event, or coronary or peripheral ischemia leading to revascularization occurred at a similarly low rate with apixaban and with placebo (0.7% and 1.0%, HR 0.67, 95% CI 0.11-3.98).

The only major bleeding event in the apixaban group was a 3-mm parafalcine subdural hematoma after a fall from a horse that didn't lead to hospitalization or drug discontinuation after neurosurgical consultation.

Among the additional safety findings, one patient in the apixaban group and three in the placebo group died, but no deaths were attributed to cardiovascular or hemorrhagic causes.

"Extended anticoagulation can offer substantial benefit to selected patients with provoked VTE but only if we are able to identify them accurately," Zakai wrote. "Future prevention strategies should blend scientific evidence, clinician judgment, and patient values. The goal is not simply to decide whether to extend therapy but to know for whom the benefits outweigh the risks -- and how patients and treating clinicians weigh those benefits and risks. The 'provoked' label should not end the conversation regarding the duration of anticoagulation; it should be the opening to an individualized patient-centered conversation."

Disclosures

HI-PRO was supported by a research grant from the Bristol-Myers Squibb (BMS)-Pfizer Alliance.

Piazza disclosed relationships with Alexion Pharmaceuticals, Amgen, Bayer, Boston Scientific, BMS, Esperion Therapeutics, Janssen Global Services, NAMSA, Penumbra, Pfizer, Regeneron Pharmaceuticals, and Thrombolex.

Zakai disclosed no relationships with industry.